MAKING THE MOST OF YOUR MONEYLETTER SUBSCRIPTION

February 27, 2015 Volume 19, Issue 9 Hotline # (410) 528-1804 MAKING THE MOST OF YOUR MONEYLETTER SUBSCRIPTION MLP T. Rowe Price Portfolio Current ...
5 downloads 0 Views 261KB Size
February 27, 2015

Volume 19, Issue 9

Hotline # (410) 528-1804

MAKING THE MOST OF YOUR MONEYLETTER SUBSCRIPTION MLP T. Rowe Price Portfolio Current Asset Allocations Bond 20% Domes tic Stock 50%

Money Funds 10%

Int'l Stock 20%

2015 MONEYLETTER Publishing Schedule: Upcoming Issues Issue

Web Post (12p ET Wed)

Maildate (Fri)

March 2015

Mar 4

Mar 6

April 2015

April 8

Apr 10

Top 5 Funds YTD All Categories Year-to-Date Ticker

Fund

Through 2/20/15

1 XBI

SPDR S&P Biotech

14.4%

2 ESR

iShares MSCI Emerging Markets Eastern Europe

13.9

3 PJP

PowerShares Dynamic Pharmaceuticals

13.4

4 FSDAX Fidelity Select Defense & Aerospace

11.6

5 FBIOX Fidelity Select Biotechnology

11.5

MLP T. Rowe Price Model 1/31/15

Purchase Return Shares Share Date Since Price Buy TRP T-E MF TRP Blue Chip 9/30/13 23.4% Growth (TRBCX) TRP Diversi1/24/14 7.5 fied SC Growth (PRDSX) TRP Growth 10/31/14 0.5 Stock (PRGFX) TRP Equity 4/21/14 1.5 Income (PRFDX) TRP Global 7/7/14 -1.2 Stock (PRGSX) TRP Emerging 7/11/14 -5.3 Markets Bond (PREMX) TRP Strategic 9/30/13 6.8 Income (PRSNX) TRP Floating 9/30/13 3.4 Rate (PRFRX) TOTAL VALUE ** Inception = 9/30/13

TOTAL RETURNS (as of 1/31/15)

Value

2500

$1.00

$2,500

69

67.34

4,626

171

25.43

4,351

57

51.88

2,973

83

31.51

2,630

111

25.27

2,806

215

12.06

2,592

237

11.27

2,670

246

9.88

2,431 $27,579

1Month

6Month

1Year

3Year

YTD

-0.4%

1.8%

4.9%

n/a

-0.4%

ETF CORNER

ML Plus Select ETF Model Current Holdings ICF 20%

PBE 20%

PJP 20%

QQQ 20%

EPI 20% MLP Select ETF Model

ML Plus Select ETF Commentary

1/31/15

Based on an update of our “Fund Scorecard & Recommendations,” which include closing market prices through February 25th, there were no fund exchanges recommended. As market indices continue to flirt with record levels we seem to have fallen into a range-bound pattern. Continued volatility in the energy sector -- along with a mixed bag of economic data -- has kept the outlook for global growth muted, leaving investors running in place. While in Congressional testimony Fed Chairman Yellen continues to assert that interest rates will remain low, pundits are left to debate the significance of a possible elimination of the word “patient” in the Fed’s guidance. As we come to month-end we will examine rebalancing transactions, particularly in light of the continued strength of the Biotech and Pharmaceutical sectors. Those sectors and model positions have again led weekly performance, with PowerShares Dynamic Biotech & Genome (PBE) and PowerShares Dynamic Pharmaceuticals (PJP) advancing 3.09% and 1.53% respectively.

Fund

PRI Financial Advisors ♦

Toll-Free: (800) 707-2060

9 $1.00

$9

PowerShares Dynamic Biotech & Genome (PBE)

10/17/14 16.3% 1,171 52.97

62,028

PowerShares QQQ (QQQ)

10/17/14

571 101.10

57,731

WisdomTree India Earnings (EPI)

1/30/15

0.0 2,291 23.45

53,724

9.1

PowerShares 10/03/14 Dynamic Pharmaceuticals (PJP)

12.5

826 70.15

57,948

iShares Cohen & Steers REIT (ICF)

18.6

611 103.83

63,431

10/17/14

TOTAL VALUE

$294,871

Email: [email protected]



Value

Schwab MMF

For a free, no-obligation Portfolio Review contact:



Purchase Return Shares Share Date Since Price Buy

Inception = 5/15/06

Fax: (508) 429-0940

More Info: www.priadvisors.com 2

TOTAL RETURNS (as of 1/31/15)

1Month

2.5%

6Month

1Year

3Year

7.5% 8.3% 54.3%

YTD

2.5%

Domestic Stock Funds — data through 2/20/15 Rank

Con

Mod Ven

Ticker

Fund

1

FDEGX

Fidelity Growth Strategies (1.5%r